Article
Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA Microarray
1 Jun 2001
Abstract excerpt
The application of genome-wide expression profiling to determine how drugs achieve their therapeutic effect has provided the pharmaceutical industry with an exciting new tool for drug mode-of-action studies. We used DNA chip technology to study cellular responses to perturbations of ergosterol biosynthesis caused by the broad-spectrum antifungal agent itraconazole. Simultaneous examination of over 6,600 Candida...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
